Eurofins Scientific SE
ERF
Rang in Aktien
#1379
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Aktienkurs
$93.33
Marktkapitalisierung
$16.20B
Veränderung (1 Tag)
-0.33%
Veränderung (1 Jahr)
25.44%
Land
LU
Handel Eurofins Scientific SE (ERF)
Kategorie
Healthcare
Gewinn für Eurofins Scientific SE (ERF)
Gewinn im Jun 2026 TTM: $862.10M
Laut den aktuellen Finanzberichten von Eurofins Scientific SE betragen die aktuellen Gewinne des Unternehmens $862.10M. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $577.10M, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $467.94M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Eurofins Scientific SE von 2002 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $862.10M | 12.35% |
| 2025 | $767.32M | 32.96% |
| 2024 | $577.10M | 23.33% |
| 2023 | $467.94M | -44.07% |
| 2022 | $836.69M | -30.36% |
| 2021 | $1.20B | 42.07% |
| 2020 | $845.69M | 177.62% |
| 2019 | $304.62M | -8.54% |
| 2018 | $333.07M | 10.99% |
| 2017 | $300.10M | 17.56% |
| 2016 | $255.27M | 77.62% |
| 2015 | $143.72M | 17.22% |
| 2014 | $122.61M | 0.11% |
| 2013 | $122.48M | 13.68% |
| 2012 | $107.74M | 18.11% |
| 2011 | $91.22M | 88.59% |
| 2010 | $48.37M | -1,720.16% |
| 2009 | $-2.99M | -107.78% |
| 2008 | $38.37M | -9.89% |
| 2007 | $42.58M | 4.56% |
| 2006 | $40.72M | 46.24% |
| 2005 | $27.85M | 72.80% |
| 2004 | $16.11M | 196.15% |
| 2003 | $5.44M | 145.28% |
| 2002 | $2.22M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $7.61B | 782.61% |
US
|
|
| $4.76B | 452.37% |
US
|
|
| $-252.70M | -129.31% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 92.32% |
US
|
